Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia

被引：2
|
作者：
Niscola, Pasquale [1 ]
Neri, Benedetta [1 ]
Catalano, Gianfranco [1 ]
Morino, Luciana [1 ]
Giovannini, Marco [1 ]
Scaramucci, Laura [1 ]
Fratoni, Stefano [2 ]
Noguera, Nelida Ines [3 ]
Cordone, Iole [4 ]
de Fabritiis, Paolo [1 ]
机构：
[1] S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] S Eugenio Hosp, Pathol Unit, Rome, Italy
[3] Santa Lucia Fdn, Neuro Oncohematol Unit, Rome, Italy
[4] Regina Elena Inst Canc Res, Clin Pathol, Rome, Italy
来源：
ACTA ONCOLOGICA | 2017年 / 56卷 / 08期
关键词：
OLDER PATIENTS; 1ST-LINE TREATMENT; PHASE-III; MULTICENTER; CHEMOTHERAPY; TRIAL; UNFIT;
D O I：
10.1080/0284186X.2017.1287947
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [1] Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia
    Aldoss, Ibrahim
    Uy, Geoffrey L.
    Vey, Norbert
    Emadi, Ashkan
    Sayre, Peter H.
    Walter, Roland B.
    Foster, Matthew C.
    Arellano, Martha L.
    Godwin, John E.
    Wieduwilt, Matthew J.
    Byrne, Michael T.
    Michaelis, Laura C.
    Stiff, Patrick J.
    Carrabba, Matteo Giovanni
    Chevalier, Patrice
    Gyan, Emmanuel
    Recher, Christian
    Advani, Anjali S.
    Wermke, Martin
    Erba, Harry P.
    Ciceri, Fabio
    Huls, Geert
    Jongen-Lavrencic, Mojca
    Topp, Max S.
    Curti, Antonio
    Ravandi, Farhad
    Rettig, Michael P.
    Muth, John
    Collins, Mary Beth
    Timmeny, Erin
    Guo, Kuo
    Zhao, Jian
    Tran, Kathy
    Kaminker, Patrick
    Patel, Priyanka
    Bakkacha, Ouiam
    Curtis, Teia
    Jacobs, Kenneth
    Kostova, Maya
    Seiler, Jennifer
    Lowenberg, Bob
    Rutella, Sergio
    Bonvini, Ezio
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    BLOOD, 2020, 136
  • [2] Decitabine-Based Salvage Therapy in Adults with Acute Myeloid Leukemia
    Ritchie, Ellen K.
    Arnason, Jon
    Feldman, Eric J.
    Gergis, Usama S.
    Mayer, Sebastian A.
    Ippoliti, Cindy
    Scandura, Joseph M.
    Roboz, Gail
    BLOOD, 2009, 114 (22) : 815 - 815
  • [3] Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
    Ferraro, Francesca
    Gruszczynska, Agata
    Ruzinova, Marianna B.
    Miller, Christopher A.
    Percival, Mary Elizabeth
    Uy, Geoffrey L.
    Pusic, Iskra
    Jacoby, Meagan A.
    Christopher, Mathew J.
    Kim, Miriam Y.
    Westervelt, Peter
    Cashen, Amanda F.
    Schroeder, Mark A.
    DiPersio, John F.
    Abboud, Camille N.
    Wartman, Lukas D.
    Gao, Feng
    Link, Daniel C.
    Ley, Timothy J.
    Welch, John S.
    HAEMATOLOGICA, 2022, 107 (07) : 1709 - 1713
  • [4] Salvage therapy must not delay allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients in primary induction failure
    Ledoux, M. -P.
    Fohrer-Sonntag, C.
    Toussaint, E.
    Fornecker, L. -M.
    Natarajan-Ame, S.
    Bilger, K.
    Lioure, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S287 - S287
  • [5] Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
    Bohl, Stephan R.
    Bullinger, Lars
    Ruecker, Frank G.
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (05) : 361 - 371
  • [6] Outcomes with Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine as Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia
    Boddu, Prajwal
    Jain, Nitin
    Ravandi, Farhad
    Manero, Guillermo Garcia
    Borthakur, Gautam
    Kadia, Tapan
    Jabbour, Elias J.
    Pemmaraju, Naveen
    Clatter, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Alvarado, Yesid
    Takahashi, Koichi
    Benton, Christopher
    Pike, Allison
    Pierce, Sherry
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S3 - S4
  • [7] Decitabine for acute myeloid leukemia
    Marks, Peter W.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) : 299 - 305
  • [8] Decitabine in acute myeloid leukemia
    Lübbert, M
    Minden, M
    SEMINARS IN HEMATOLOGY, 2005, 42 (03) : S38 - S42
  • [9] Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
    M Wattad
    D Weber
    K Döhner
    J Krauter
    V I Gaidzik
    P Paschka
    M Heuser
    F Thol
    T Kindler
    M Lübbert
    H R Salih
    A Kündgen
    H-A Horst
    P Brossart
    K Götze
    D Nachbaur
    C-H Köhne
    M Ringhoffer
    G Wulf
    G Held
    H Salwender
    A Benner
    A Ganser
    H Döhner
    R F Schlenk
    Leukemia, 2017, 31 : 1306 - 1313
  • [10] Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
    Wattad, M.
    Weber, D.
    Doehner, K.
    Krauter, J.
    Gaidzik, V. I.
    Paschka, P.
    Heuser, M.
    Thol, F.
    Kindler, T.
    Luebbert, M.
    Salih, H. R.
    Kuendgen, A.
    Horst, H-A
    Brossart, P.
    Goetze, K.
    Nachbaur, D.
    Koehne, C-H
    Ringhoffer, M.
    Wulf, G.
    Held, G.
    Salwender, H.
    Benner, A.
    Ganser, A.
    Doehner, H.
    Schlenk, R. F.
    LEUKEMIA, 2017, 31 (06) : 1306 - 1313
12345